Ketamine May Help Cure Treatment Resistant Depression Ketamine is a drug of disrepute and had been associated with numerous instances of date rape in the past. It’s an anesthetic, causing a loss of consciousness and relieving in pain. Therefore, despite its extensive recreational use, many experts have always insisted on exploiting the drug more for its medicinal abilities. Their claim was supported by a successful phase 3 trial of intranasal esketamine (Janssen) – a left handed isomer of ketamine – along with antidepressants for safe and effective treatment of treatment resistant depression (TRD). TRD is a form of depression that does not respond favorably to the usual treatment with antidepressants. Antidepressants are currently considered de rigueur for major depressive disorder (MDD) cure. However, in TRD patients there is no observable impact of these medicines. The study found that patients who had received treatment with antidepressants and esketamine spray had greater improvement in the MontgomeryÅsberg Depression Rating Scale (MADRS) score compared to those who had received only antidepressant and placebo. MADRS is key for measuring the severity of depression in a person. The study also revealed that while the response rate of the respondents involved in the survey was 70 percent, the remission rate was a striking 53 percent. There are many who consider the drug to be a game changer. According to the American Psychiatric Association Secretary Dr. Philip Muskin, the current study was an interesting and novel approach for treating a patient population indifferent to standard treatment. Side effects of ketamine The drug, however, has noticeable side effects. It is a psychoactive drug and is associated with nausea, dissociation or a feeling of being detached from one’s body, hallucinations, and is also
www.recovermentalhealth.com